Pfizer Takes Top Spot in Pharma Market Cap for 2018, Analysis Shows

In the battle of titans, Pfizer has emerged on top as the most valuable pharma company by market cap for 2018. According to an analysis conducted by GlobalData, Pfizer replaced Swiss-based pharma giant Roche at the top of the mountain with a market cap of $253.2 billion. Roche, which came in at number 2 on the list, had a market cap of $212.5 billion, according to the report. Roche and Pfizer are the only two pharmaceutical companies to cross the $200 billion market cap threshold. While Pfizer has the largest market cap, GlobalData’s survey shows that Roche actually generated more revenue during 2018, $58.1 billion to $53.6 billion. Merck & Company took the third spot with a market cap of $198.7 billion and Novartis came in right behind in fourth place with a market cap of $198.4 billion. Illinois-based AbbVie rounds out the top five with a market cap of $139.6 billion – nearly $60 billion lower than Novartis.